周围静脉氧和可以预测儿科扩张性心肌病的临床减补吗?
Yasemin Özdemir Şahan1, Emine Gülşah Torun1, İbrahim Ece1
1Department of Pediatric Cardiology, Ankara City Hospital, Ankara, Turkiye.
周围静脉氧和 (SpvO2) 有效地预测了儿科扩张性心肌病 (DCM) 患者的不补偿性心力衰竭和死亡率. 60.7%的SpvO2水平表明高风险,特别是在诊断后的前三个月内.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 心血管研究研究心血管研究
- 生物医学工程 生物医学工程
背景情况:
- 患有扩张性心肌病症 (DCM) 的儿童经常因心力衰竭而面临住院治疗.
- 氧气利用率下降是不补偿性心力衰竭的一个关键特征.
- 周围静脉氧和度 (SpvO2) 可能表明氧气供需之间的平衡.
研究的目的:
- 评估SpvO2对儿科DCM临床失补偿的预测能力.
- 评估SvO2与儿童DCM患者死亡风险之间的关联.
主要方法:
- 55名儿科DCM患者 (2019-2023) 的回顾性分析.
- 收集的周围静脉血液气体数据 (SpvO2,乳酸盐,pH,二碳酸盐),N-终端亲B型尿素和心声学参数 (EF,分数缩短).
- 根据临床状态和已建立的评分系统,将患者分为稳定和不稳定 (无补偿) 组.
主要成果:
- 在没有补偿的患者中观察到左下心室喷射分数 (EF) 和SpvO2,以及更高的N-终端亲B型尿素.
- 60.7%的SpvO2截止值显示了90%的灵敏度和85%的特异性来预测脱补偿.
- SpvO2 ≤ 60.7% 的患者在12个月内死亡率更高 (P=.031),特别是在3个月内 (P=.035).
结论:
- 周围静脉氧和 (SpvO2) 是儿科DCM中无补偿性心力衰竭的一个有价值的预测指标.
- 在这个人群中,SpvO2 作为识别死亡风险的有用标志物.
- 该参数补充了现有的临床和实验室评估,以改善患者管理.
更多相关视频
14:28Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
Published on: May 10, 2024
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
相关概念视频
Special considerations while measuring oxygen saturation
Ensuring accuracy in vital sign recordings while prioritizing patient comfort and minimizing anxiety is...
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
Cardiomyopathy II: Dilated Cardiomyopathy
Pulse Oximetry
Purpose
Average SpO2 values are greater than 95%. If the readings fall below 90%, it indicates that...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Guidelines For Measuring Vital Signs
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.
